Acetazolamide Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-661

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 68083-661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Acetazolamide-spl-carton (Acetazolamide Spl Carton)

The text provides information about a medication called acetazolamide sodium in injectable form, with each vial containing 500 mg of the active ingredient. The medication is manufactured by NDC (National Drug Code) and is for prescription use only. It includes details on the storage conditions, recommended dosage, and administration instructions for intravenous use. The solution needs to be reconstituted before use and stored in a refrigerator. It is important to use the reconstituted solution within 12 hours and to discard any unused portion.*

FDA Label Image

Acetazolamide-spl-container (Acetazolamide Spl Container)

This is a description of acetazolamide sodium vials containing 500 mg of acetazolamide, USP. The text includes information on how to store the vials, the usual dosage, reconstitution instructions, and shelf life. It mentions using the solution within 12 hours of reconstitution and discarding any unused portion. The manufacturer listed is Gland Pharma Limited.*

FDA Label Image

Acetazolamide-structure (Acetazolamide Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.